Aligned by a shared vision for a healthier world, a united life sciences sector is a powerful thing. In the Charleston, South Carolina, market, strong synergies between new and established businesses, academic institutions and state-led...
We’ve heard and used the term “patient centricity” for years now, and with good reason....
Dealing with consent throughout multiple data channels within healthcare is a complex issue that can...
Decentralization is one arrow in the quiver to modernize clinical trials.[1] Yet, owing to the varied...
Life science businesses like Horizon Scientific depend on Charleston’s intermodal transportation infrastructure to deliver products...
As the industry continues to shift to decentralized clinical trial (DCT) approaches, sponsors and CROs must now focus on how to make this change globally. This session will outline best…
Identifying the right sensors in support of hybrid or virtual trials is only the beginning. The ability to distill meaningful clinical insights from massive amounts of data requires a dynamic…
This session will touch upon: Identifying enrollment challenges and opportunities of Rare Disease Studies Technology solutions that can create engagement How a unified platform and centralized data can streamline the…
Many research and development (R&D) organizations across the industry have limited access to a quality department in the early stages of development. It’s imperative for organizations to be agile and flexible during each development…
What is driving the acceleration of clinical trials in the Asia Pacific region and what are key considerations to maximise the opportunity for decentralised clinical trials in the future across…
In this webinar we discuss: APACs Rare Disease landscape Asia-Pacific’s recruitment success for rare disease programs What to look for in a Rare Disease CRO partner Rare disease program strategies…
© Copyright Verdict Media Limited 2021
